Kopran Ltd (KPRN)

Currency in INR
245.90
+6.85(+2.87%)
Closed·
KOPRAN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
239.00246.27
52 wk Range
107.00295.83
Key Statistics
Bid/Ask
243.25 / 245.90
Prev. Close
239.05
Open
240.5
Day's Range
239-246.27
52 wk Range
107-295.83
Volume
222.4K
Average Volume (3m)
994.17K
1-Year Change
48.6969%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KOPRAN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has fared poorly over the last month

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Earnings

Latest Release
Aug 07, 2026
EPS / Forecast
1.39 / --
Revenue / Forecast
1.54B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.18
Dividend Yield
1.25%
Industry Median 0.65%
Annualized payout
3.00
Paid annually
5-Years Growth
-
Growth Streak

KOPRAN Income Statement

Compare KOPRAN to Peers and Sector

Metrics to compare
KOPRAN
Peers
Sector
Relationship
P/E Ratio
46.3x26.1x−0.3x
PEG Ratio
−1.630.350.00
Price/Book
2.2x2.9x2.6x
Price / LTM Sales
1.7x2.7x2.8x
Upside (Analyst Target)
-14.4%66.4%
Fair Value Upside
Unlock3.5%9.0%Unlock

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, penicillin, quinolone, anti-protozoal, sulphonamides, respiratory, tetracycline, cardiovascular, anti-diabetic, urology, pain management and anti-inflammatory, gastrointestinal, erectile dysfunction, anthemintic, anti-allergic, central nervous system, anti-malarial, anti-thyroid, and carbapenems. In addition, the company offers drugs for anti-hypertensive, neuromodulator, anti-acne, anti-infective, antibiotic, anti-thrombotic, anti-diabetic, anti-asthamatic, antihyperlipidemic, anti-convulsants, anti-anxiety, pulmonary arterial hypertension, chronic heart failure, neuropathic pain, and erosive esophagitis. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.

Employees
1156
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
107.53K0.22%25.70M
Other Institutional Investors
11.87M24.59%2.84B
Public Companies & Retail Investors
36.31M75.19%8.68B
Total
48.29M100.00%11.54B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Panorama Finvest Pvt Ltd7.87%3,800,000908,390
Sarvamangal Mercantile Company Limited6.36%3,072,951734,589

People Also Watch

266.90
KROS
-4.81%
164.99
SMBV
+8.36%

FAQ

What Is the Kopran Ltd (KOPRAN) Stock Price Today?

The Kopran Ltd stock price today is 245.90 INR.

What Stock Exchange Does Kopran Ltd Trade On?

Kopran Ltd is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Kopran Ltd?

The stock symbol for Kopran Ltd is "KOPRAN."

Does Kopran Ltd Pay Dividends? What’s The Current Dividend Yield?

The Kopran Ltd dividend yield is 1.3%%.

What Is the Kopran Ltd Market Cap?

As of today, Kopran Ltd market cap is 11.76B INR.

What Is Kopran Ltd's Earnings Per Share (TTM)?

The Kopran Ltd EPS (TTM) is 5.18.

From a Technical Analysis Perspective, Is KOPRAN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Kopran Ltd Stock Split?

Kopran Ltd has split 0 times.

How Many Employees Does Kopran Ltd Have?

Kopran Ltd has 1156 employees.

What is the current trading status of Kopran Ltd (KOPRAN)?

As of Nov 02, 2026, Kopran Ltd (KOPRAN) is trading at a price of 245.90 INR, with a previous close of 239.05 INR. The stock has fluctuated within a day range of 239.00 INR to 246.27 INR, while its 52-week range spans from 107.00 INR to 295.83 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.